Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “626”

162 pharma patents match "626" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 162
Index total 30,257
Page 3 / 7

Quick answer

This filtered view shows 162 pharmaceutical patents matching "626" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

162 results for “626” · 30,257 patents in full index Clear search

  1. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  2. US 9856264

    Isoquinolinesulfonyl derivative as RHO kinase inhibitor

    Medshine Discovery Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  3. US 9856260

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Alliance Discovery, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  4. US 9856262

    Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

    Medshine Discovery Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  5. US 9493626

    Dispersions comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  6. US 9365626

    Simukunin

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  7. US 9341626

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 17, 2016 · Expires May 12, 2036

    granted

  8. US 9102626

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  9. US 9040626

    Nanofibers and morphology shifting micelles

    The Regents of the University of California · Granted May 26, 2015 · Expires May 21, 2035

    granted

  10. US 8993626

    Methods of treatment using sterculic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  11. US 8962643

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  12. US 8962631

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  13. US 8962653

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  14. US 8962677

    Methods of restoring cognitive ability using non-peptidic compounds

    Acumen Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  15. US 8962685

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  16. US 8962637

    Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  17. US 8962663

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  18. US 8962642

    5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  19. US 8852626

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  20. US 8790626

    Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  21. US 8716265

    4-quinolinemethanols as anti-malarial agents

    Jenrin Discovery, LLC · Granted May 6, 2014 · Expires May 1, 2034

    granted

  22. US 8658626

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  23. US 8586626

    Metabolites of wortmannin analogs and methods of using the same

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  24. US 8530626

    Methods to produce keratin elastomer

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.